Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12801)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lu C, Xu CF, Wan XY, Zhu HT, Yu CH, Li YM. Screening for pancreatic cancer in familial high-risk individuals: A systematic review. World J Gastroenterol 2015; 21(28): 8678-8686 [PMID: 26229410 DOI: 10.3748/wjg.v21.i28.8678] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i28/8678.htm |
| Number | Citing Articles |
| 1 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Adenocarcinoma ductal de páncreas. Experiencia de 11 años en un centro de tercer nivel. Revista de Gastroenterología de México 2021; 86(2): 118 doi: 10.1016/j.rgmx.2020.04.004
|
| 2 |
Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives. Cancers 2020; 12(11): 3346 doi: 10.3390/cancers12113346
|
| 3 |
Alexandra R Lewis, Juan W Valle, Mairead G McNamara. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?. World Journal of Gastroenterology 2016; 22(32): 7175-7185 doi: 10.3748/wjg.v22.i32.7175
|
| 4 |
Penpa Dorjee, Zi-Wen Long. A mixed treatment comparison of toxicity of gemcitabine combined with different targeted drugs in the treatment of advanced or metastatic pancreatic cancer. Cancer Biology & Therapy 2018; 19(6): 497 doi: 10.1080/15384047.2018.1433503
|
| 5 |
Divyanshoo R. Kohli, Ken Robert Smith, Jathine Wong, Zhe Yu, Kenneth Boucher, Douglas O. Faigel, Rahul Pannala, Randall W. Burt, Karen Curtin, N. Jewel Samadder. Familial pancreatic cancer risk: a population-based study in Utah. Journal of Gastroenterology 2019; 54(12): 1106 doi: 10.1007/s00535-019-01597-3
|
| 6 |
Wataru Gonoi, Takana Yamakawa Hayashi, Hidemi Okuma, Masaaki Akahane, Yousuke Nakai, Suguru Mizuno, Ryosuke Tateishi, Hiroyuki Isayama, Kazuhiko Koike, Kuni Ohtomo. Development of pancreatic cancer is predictable well in advance using contrast-enhanced CT: a case–cohort study. European Radiology 2017; 27(12): 4941 doi: 10.1007/s00330-017-4895-8
|
| 7 |
Ji Kon Ryu. The Early Detection of Pancreatic Cancer: Whom and How?. Korean Journal of Pancreas and Biliary Tract 2015; 20(4): 198 doi: 10.15279/kpba.2015.20.4.198
|
| 8 |
Tanya Dwarte, Skye McKay, Amber Johns, Katherine Tucker, Allan D. Spigelman, David Williams, Alina Stoita. Genetic counselling and personalised risk assessment in the Australian pancreatic cancer screening program. Hereditary Cancer in Clinical Practice 2019; 17(1) doi: 10.1186/s13053-019-0129-1
|
| 9 |
Thomas Hank, Oliver Strobel. Conversion Surgery for Advanced Pancreatic Cancer. Journal of Clinical Medicine 2019; 8(11): 1945 doi: 10.3390/jcm8111945
|
| 10 |
Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer. International Journal of Molecular Sciences 2019; 20(3): 561 doi: 10.3390/ijms20030561
|
| 11 |
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care. 2019; : 1 doi: 10.1007/978-3-319-74698-2_180-1
|
| 12 |
Kasper A. Overbeek, Djuna L. Cahen, Marco J. Bruno. The role of endoscopic ultrasound in the detection of pancreatic lesions in high-risk individuals. Familial Cancer 2024; 23(3): 279 doi: 10.1007/s10689-024-00380-5
|
| 13 |
Hideyuki Fukui, Hiromitsu Onishi, Atsushi Nakamoto, Takahiro Tsuboyama, Takashi Ota, Keigo Yano, Yukihiro Enchi, Daisaku Yamada, Yu Takeda, Shogo Kobayashi, Yasunari Fukuda, Hidetoshi Eguchi, Takahiro Matsui, Mitsuaki Tatsumi, Noriyuki Tomiyama. Pancreatic fibrosis by extracellular volume fraction using Contrast-enhanced computed tomography and relationship with pancreatic cancer. European Journal of Radiology 2022; 156: 110522 doi: 10.1016/j.ejrad.2022.110522
|
| 14 |
Tianle Zou, Dan Shi, Weiwei Wang, Guoyong Chen, Xianbin Zhang, Yu Tian, Peng Gong, Jinghua Pan. Identification of a New m6A Regulator-Related Methylation Signature for Predicting the Prognosis and Immune Microenvironment of Patients with Pancreatic Cancer. Mediators of Inflammation 2023; 2023: 1 doi: 10.1155/2023/5565054
|
| 15 |
Priyanka Jha, Benjamin M. Yeh, Ronald Zagoria, Eric Collisson, Zhen J. Wang. The Role of MR Imaging in Pancreatic Cancer. Magnetic Resonance Imaging Clinics of North America 2018; 26(3): 363 doi: 10.1016/j.mric.2018.03.004
|
| 16 |
R. S. O’Neill, B. Meiser, S. Emmanuel, D. B. Williams, A. Stoita. Long-term positive psychological outcomes in an Australian pancreatic cancer screening program. Familial Cancer 2020; 19(1): 23 doi: 10.1007/s10689-019-00147-3
|
| 17 |
Jia-Qi Zhou, Zi-Xian Liu, Hong-Fa Zhong, Guan-Qiao Liu, Ming-Cong Ding, Yu Zhang, Bin Yu, Nan Jiang. Single nucleotide polymorphisms in the development of osteomyelitis and prosthetic joint infection: a narrative review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1444469
|
| 18 |
Federico Salom, Frédéric Prat. Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer. World Journal of Gastrointestinal Endoscopy 2022; 14(1): 35-48 doi: 10.4253/wjge.v14.i1.35
|
| 19 |
Sung Bum Kim. Model to Stratify Risk of Pancreatic Cancer in Patients Diagnosed as New-onset Diabetes. The Korean Journal of Gastroenterology 2018; 72(3): 159 doi: 10.4166/kjg.2018.72.3.159
|
| 20 |
Julia Benzel, Volker Fendrich. Familial Pancreatic Cancer. Oncology Research and Treatment 2018; 41(10): 611 doi: 10.1159/000493473
|
| 21 |
Ankit Chhoda, Lingeng Lu, Barbara M. Clerkin, Harvey Risch, James J. Farrell. Current Approaches to Pancreatic Cancer Screening. The American Journal of Pathology 2019; 189(1): 22 doi: 10.1016/j.ajpath.2018.09.013
|
| 22 |
Jingjing Lyu, Xin Guan, Yuhan Zhou, Huan Guo, Shanshan Cheng, Chaolong Wang. Risk prediction of hepatobiliary and pancreatic cancers in elderly Chinese: The Dongfeng‐Tongji cohort. Journal of Evidence-Based Medicine 2023; 16(1): 39 doi: 10.1111/jebm.12516
|
| 23 |
Joan Llach, Paula Aguilera, Ariadna Sánchez, Angels Ginès, Glòria Fernández-Esparrach, Guillem Soy, Oriol Sendino, Eva Vaquero, Sabela Carballal, Fabio Ausania, Juan Ramón Ayuso, Anna Darnell, María Pellisé, Sergi Castellví-Bel, Susana Puig, Francesc Balaguer, Leticia Moreira. Pancreatic Cancer Surveillance in Carriers of a Germline Pathogenic Variant in CDKN2A. Cancers 2023; 15(6): 1690 doi: 10.3390/cancers15061690
|
| 24 |
Jonathan D Mizrahi, Rishi Surana, Juan W Valle, Rachna T Shroff. Pancreatic cancer. The Lancet 2020; 395(10242): 2008 doi: 10.1016/S0140-6736(20)30974-0
|
| 25 |
Elisabeth King, Bita Nehoray. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families. Clinical Journal of Oncology Nursing 2019; 23(6): 579 doi: 10.1188/19.CJON.579-582
|
| 26 |
Chris M. Lindquist, Frank H. Miller, Nancy A. Hammond, Paul Nikolaidis. Pancreatic cancer screening. Abdominal Radiology 2018; 43(2): 264 doi: 10.1007/s00261-017-1308-z
|
| 27 |
Juan E. Corral, Ananya Das, Marco J. Bruno, Michael B. Wallace. Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals. Pancreas 2019; 48(4): 526 doi: 10.1097/MPA.0000000000001268
|
| 28 |
R. Vera, A. Ferrández, C. J. Ferrer, C. Flores, C. Joaquín, S. López, T. Martín, E. Martín, M. Marzo, A. Sarrión, E. Vaquero, A. Zapatero, J. Aparicio. Procedures and recommended times in the care process of the patient with pancreatic cancer: PAN-TIME consensus between scientific societies. Clinical and Translational Oncology 2017; 19(7): 834 doi: 10.1007/s12094-016-1609-7
|
| 29 |
Amr F. Mourad, Mona M. Sayed, Hussein Fakhry. Is magnetic resonance diffusion-weighted imaging superior in the diagnosis of pancreatic adenocarcinoma and does it have a prognostic value?. The Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4): 908 doi: 10.1016/j.ejrnm.2018.06.001
|
| 30 |
Elisabeth Maurer, Detlef K. Bartsch. Surgical aspects related to hereditary pancreatic cancer. Familial Cancer 2024; 23(3): 341 doi: 10.1007/s10689-024-00384-1
|
| 31 |
Kai Jia, Steven Kundrot, Matvey B. Palchuk, Jeff Warnick, Kathryn Haapala, Irving D. Kaplan, Martin Rinard, Limor Appelbaum. A pancreatic cancer risk prediction model (Prism) developed and validated on large-scale US clinical data. eBioMedicine 2023; 98: 104888 doi: 10.1016/j.ebiom.2023.104888
|
| 32 |
Elena M. Stoffel, Shannon E. McKernin, Randall Brand, Marcia Canto, Michael Goggins, Cassadie Moravek, Arun Nagarajan, Gloria M. Petersen, Diane M. Simeone, Matthew Yurgelun, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion. Journal of Clinical Oncology 2019; 37(2): 153 doi: 10.1200/JCO.18.01489
|
| 33 |
Louis de Mestier, Jean-Baptiste Danset, Cindy Neuzillet, Vinciane Rebours, Jérôme Cros, Nadem Soufir, Pascal Hammel. Pancreatic ductal adenocarcinoma in BRCA2 mutation carriers. Endocrine-Related Cancer 2016; 23(10): T57 doi: 10.1530/ERC-16-0269
|
| 34 |
Negar Khoshghamat, Niloufar Jafari, Vajiheh Toloue-pouya, Shakiba Azami, Seyyedeh Helya Mirnourbakhsh, Majid Khazaei, Gordon A. Ferns, Majid Rajabian, Amir Avan. The therapeutic potential of renin-angiotensin system inhibitors in the treatment of pancreatic cancer. Life Sciences 2021; 270: 119118 doi: 10.1016/j.lfs.2021.119118
|
| 35 |
Fundamentals of Cancer Detection, Treatment, and Prevention. 2022; : 341 doi: 10.1002/9783527838561.ch15
|
| 36 |
M.-P. Vullierme, M. Lagadec. Facteurs prédisposants de l’adénocarcinome pancréatique : quel est le rôle de l’imagerie ?. Journal de Radiologie Diagnostique et Interventionnelle 2016; 97(5): 509 doi: 10.1016/j.jradio.2016.10.003
|
| 37 |
Jérôme Schwingel, Miriam Decker, Lisa Schneider, Carsten Johannes Stürmer, Manfred P. Lutz. Early Detection of Pancreatic Cancer. Oncology Research and Treatment 2023; 46(6): 259 doi: 10.1159/000530790
|
| 38 |
Olga Partyka, Monika Pajewska, Daria Kwaśniewska, Aleksandra Czerw, Andrzej Deptała, Michał Budzik, Elżbieta Cipora, Izabela Gąska, Lucyna Gazdowicz, Aneta Mielnik, Katarzyna Sygit, Marian Sygit, Edyta Krzych-Fałta, Daria Schneider-Matyka, Szymon Grochans, Anna M. Cybulska, Jarosław Drobnik, Ewa Bandurska, Weronika Ciećko, Piotr Ratajczak, Karolina Kamecka, Michał Marczak, Remigiusz Kozłowski. Overview of Pancreatic Cancer Epidemiology in Europe and Recommendations for Screening in High-Risk Populations. Cancers 2023; 15(14): 3634 doi: 10.3390/cancers15143634
|
| 39 |
Kjetil Søreide, Warsan Ismail, Marcus Roalsø, Jacob Ghotbi, Claudia Zaharia. Early Diagnosis of Pancreatic Cancer: Clinical Premonitions, Timely Precursor Detection and Increased Curative-Intent Surgery. Cancer Control 2023; 30 doi: 10.1177/10732748231154711
|
| 40 |
I.J.M. Levink, D.C.F. Klatte, R.G. Hanna-Sawires, G.C.M. Vreeker, I.S. Ibrahim, Y.E.M. van der Burgt, K.A. Overbeek, B.D.M. Koopmann, D.L. Cahen, G.M. Fuhler, M. Wuhrer, B.A. Bonsing, R.A.E.M. Tollenaar, F.P. Vleggaar, H.F.A. Vasen, M.E. van Leerdam, M.J. Bruno, W.E. Mesker. Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals. Pancreatology 2022; 22(4): 497 doi: 10.1016/j.pan.2022.03.021
|
| 41 |
Isaura S. Ibrahim, Hans F. A. Vasen, Martin N. J. M. Wasser, Shirin Feshtali, Bert A. Bonsing, Hans Morreau, Akin Inderson, Wouter H. de Vos tot Nederveen Cappel, Wilbert B. van den Hout. Cost‐effectiveness of pancreas surveillance: The CDKN2A‐p16‐Leiden cohort. United European Gastroenterology Journal 2023; 11(2): 163 doi: 10.1002/ueg2.12360
|
| 42 |
Elena M. Stoffel, Shannon E. McKernin, Alok A. Khorana. Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary. Journal of Oncology Practice 2019; 15(2): 108 doi: 10.1200/JOP.18.00629
|
| 43 |
Ankit Chhoda, Ziga Vodusek, Kapil Wattamwar, Eric Mukherjee, Craig Gunderson, Alyssa Grimshaw, Anup Sharma, Nita Ahuja, Fay Kastrinos, James J. Farrell. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis. Gastroenterology 2022; 162(3): 786 doi: 10.1053/j.gastro.2021.11.021
|
| 44 |
Juan Pablo Hinestrosa, Rosalie C. Sears, Harmeet Dhani, Jean M. Lewis, Gregor Schroeder, Heath I. Balcer, Dove Keith, Brett C. Sheppard, Razelle Kurzrock, Paul R. Billings. Development of a blood-based extracellular vesicle classifier for detection of early-stage pancreatic ductal adenocarcinoma. Communications Medicine 2023; 3(1) doi: 10.1038/s43856-023-00351-4
|
| 45 |
Griffin P. J. McNamara, Karla N. Ali, Shraddha Vyas, Tri Huynh, Monica Nyland, Deanna Almanza, Christine Laronga, Jason Klapman, Jennifer B. Permuth. Characteristics and Clinical Outcomes of Individuals at High Risk for Pancreatic Cancer: A Descriptive Analysis from a Comprehensive Cancer Center. Gastrointestinal Disorders 2018; 1(1): 106 doi: 10.3390/gidisord1010008
|
| 46 |
Katherina P. Farr, Daniel Moses, Koroush S. Haghighi, Phoebe A. Phillips, Claudia M. Hillenbrand, Boon H. Chua. Imaging Modalities for Early Detection of Pancreatic Cancer: Current State and Future Research Opportunities. Cancers 2022; 14(10): 2539 doi: 10.3390/cancers14102539
|
| 47 |
Juan E. Corral, Karl F. Mareth, Douglas L. Riegert-Johnson, Ananya Das, Michael B. Wallace. Diagnostic Yield From Screening Asymptomatic Individuals at High Risk for Pancreatic Cancer: A Meta-analysis of Cohort Studies. Clinical Gastroenterology and Hepatology 2019; 17(1): 41 doi: 10.1016/j.cgh.2018.04.065
|
| 48 |
Akiko Kowada. Cost-effectiveness of Abdominal Ultrasound Versus Magnetic Resonance Imaging for Pancreatic Cancer Screening in Familial High-Risk Individuals in Japan. Pancreas 2020; 49(8): 1052 doi: 10.1097/MPA.0000000000001614
|
| 49 |
M.-P. Vullierme, M. Lagadec. Predisposing factors for pancreatic adenocarcinoma: What is the role of imaging?. Diagnostic and Interventional Imaging 2016; 97(12): 1233 doi: 10.1016/j.diii.2016.08.018
|
| 50 |
Uwe Pelzer. Pankreaskarzinom – Therapiestandards und spezielle Situationen. best practice onkologie 2018; 13(5): 238 doi: 10.1007/s11654-018-0098-2
|
| 51 |
Kristine McCarthy, Wei Zhang, Jose Soliz, Danilo Lovinaria. Oncologic Critical Care. 2020; : 1809 doi: 10.1007/978-3-319-74588-6_180
|
| 52 |
Jonathan Kandiah, Tammy Lo, Dugho Jin, Landon Melchior, Thorsten L. Krebs, Naveen Anand, Susan Ingram, Pramila Krumholtz, Deep Pandya, Antolin Trinidad, Xiang (Eric) Dong, Ramanathan Seshadri, James Bauman, Ronald Lee, Richard C. Frank. A Community-Based Pancreatic Cancer Screening Study in High-Risk Individuals: Preliminary Efficacy and Safety Results. Clinical and Translational Gastroenterology 2022; 13(8): e00516 doi: 10.14309/ctg.0000000000000516
|
| 53 |
Andrew McGuigan, Paul Kelly, Richard C Turkington, Claire Jones, Helen G Coleman, R Stephen McCain. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology 2018; 24(43): 4846-4861 doi: 10.3748/wjg.v24.i43.4846
|
| 54 |
Hiroki Sato, Andrew Scott Liss, Yusuke Mizukami. Large-duct pattern invasive adenocarcinoma of the pancreas–a variant mimicking pancreatic cystic neoplasms: A minireview. World Journal of Gastroenterology 2021; 27(23): 3262-3278 doi: 10.3748/wjg.v27.i23.3262
|
| 55 |
Salvatore Paiella, Erica Secchettin, Gabriella Lionetto, Livia Archibugi, Danila Azzolina, Fabio Casciani, Diane M Simeone, Kasper A Overbeek, Michael Goggins, James Farrell, Ruggero Ponz de Leon Pisani, Maddalena Tridenti, Maria Assunta Corciulo, Giuseppe Malleo, Paolo Giorgio Arcidiacono, Massimo Falconi, Dario Gregori, Claudio Bassi, Roberto Salvia, Gabriele Capurso. Surveillance of Individuals at High Risk of Developing Pancreatic Cancer. Annals of Surgery 2023; doi: 10.1097/SLA.0000000000006094
|
| 56 |
Kari G. Rabe, Maria A. Stevens, Amanda Toledo Hernández, Shruti Chandra, Joleen M. Hubbard, Jennifer L. Kemppainen, Shounak Majumder, Gloria M. Petersen. Pancreatic cancer risk to siblings of probands in bilineal cancer settings. Genetics in Medicine 2022; 24(5): 1008 doi: 10.1016/j.gim.2022.01.016
|
| 57 |
Elisabeth Maurer, Bettina Lehman, Elvira Matthäi, Ulrike Denzer, Jens Figiel, Moritz Jesinghaus, Emily P. Slater, Ulrich Stefenelli, Thomas M. Gress, Detlef K. Bartsch. Pancreatic cancer screening is effective in individuals at risk with predisposing germline gene variants, but not in gene variant‐negative familial pancreatic cancer families. United European Gastroenterology Journal 2024; 12(9): 1211 doi: 10.1002/ueg2.12631
|
| 58 |
Lauren Fried, Andrea Tan, Shirin Bajaj, Tracey N. Liebman, David Polsky, Jennifer A. Stein. Technological advances for the detection of melanoma. Journal of the American Academy of Dermatology 2020; 83(4): 996 doi: 10.1016/j.jaad.2020.03.122
|
| 59 |
Tian-Bao Yan, Jia-Qi Huang, Shi-Yun Huang, Bhavesh K. Ahir, Long-Man Li, Zeng-Nan Mo, Jian-Hong Zhong. Advances in the Detection of Pancreatic Cancer Through Liquid Biopsy. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.801173
|
| 60 |
Randa G. Hanna-Sawires, Jorinde H. Schiphuis, Manfred Wuhrer, Hans F. A. Vasen, Monique E. van Leerdam, Bert A. Bonsing, Wilma E. Mesker, Yuri E. M. van der Burgt, Rob A. E. M. Tollenaar. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer. International Journal of Molecular Sciences 2021; 22(5): 2655 doi: 10.3390/ijms22052655
|
| 61 |
Robert Wittram, Hans-Helmut König, Christian Brettschneider. Economic evaluations of pancreatic cancer screening: a systematic review protocol. BMJ Open 2024; 14(8): e087003 doi: 10.1136/bmjopen-2024-087003
|
| 62 |
Natalia Khalaf, Basim Ali. New-onset Diabetes as a Signpost of Early Pancreatic Cancer: The Role of Screening. Clinical Gastroenterology and Hepatology 2022; 20(9): 1927 doi: 10.1016/j.cgh.2022.02.015
|
| 63 |
G.E. Sánchez Morales, R.A. Moguel Valladares, J. Flores Maza, U. Clemente Gutiérrez, E. Sánchez-García Ramos, I. Domínguez Rosado, L.C. Chan Núñez. Pancreatic ductal adenocarcinoma: Eleven years of experience at a tertiary care hospital center. Revista de Gastroenterología de México (English Edition) 2021; 86(2): 118 doi: 10.1016/j.rgmxen.2020.04.005
|
| 64 |
|
| 65 |
Louis de Mestier, Marie Muller, Jérôme Cros, Marie-Pierre Vullierme, Dewi Vernerey, Frédérique Maire, Safi Dokmak, Vinciane Rebours, Alain Sauvanet, Philippe Lévy, Pascal Hammel. Appropriateness of pancreatic resection in high‐risk individuals for familial pancreatic ductal adenocarcinoma: a patient‐level meta‐analysis and proposition of the Beaujon score. United European Gastroenterology Journal 2019; 7(3): 358 doi: 10.1177/2050640618824910
|